November 04, 2026 at 09:03 PM UTC

8-K - Niagen Bioscience, Inc. (0001386570) (Filer)

Filed: 2026-11-04 AccNo: 0001386570-26-000057 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Official source: U.S. Securities and Exchange Commission

Official source published: November 04, 2026 at 09:01 PM UTC

Open official source